IP Library › Granted Patent US 10,866,236
Granted Patent B2
US 10,866,236 · App. 15/031,600 · Granted Dec 15, 2020

Detection of cleavage activity of an enzyme

Inventors: Paul Davis (Sharnbrook, GB); Gita Parekh (Milton Keynes, GB); James Schouten (Thurleigh, GB)
Assignee: Mologic Limited
G01N33/54386C12Q1/37G01N33/558G01N33/573G01N2333/96486G01N2800/12G01N2800/382
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,866,236
App. No.
15/031,600
Granted
Dec 15, 2020
Kind
B2
Abstract

The present invention relates to detecting cleavage activity of an enzyme. The various aspects of the invention include an enzyme detection device, kit, method and use for detecting or measuring the presence in a test sample of the activity of an enzyme capable of cleaving a substrate. The invention also relates to indicator and binding molecules useful for carrying out the invention. The enzyme substrate contains a hidden binding site which is only revealed upon cleavage by the enzyme.

Claims (7)

1. An enzyme detection kit for detecting the presence of cleavage activity of an enzyme, the kit comprising:

(i) an intact indicator molecule, the intact indicator molecule comprising

(a) a cleavage region comprising at least one cleavage site that is specific for the enzyme, the cleavage region defining an end of a detectable fragment or cleavage part of the indicator molecule when the intact indicator molecule is cleaved at the cleavage site, the detectable fragment or cleavage part of the indicator molecule comprising a binding site, wherein the binding site of the detectable fragment or cleavage part of the indicator molecule is a conformational epitope that is not formed in the intact indicator molecule; and

(b) a capture site which is present in the intact indicator molecule and is present in the detectable fragment or cleavage part of the indicator molecule;

(ii) capture molecules which are (a) capable of binding to the capture site of the intact indicator molecule and (b) capable of binding to the capture site of the detectable fragment or cleavage part of the indicator molecule;

(iii) a solid support to which the capture molecules are attachable or attached to form a capture zone; and

(iv) binding molecules which are (a) capable of binding to the binding site of the detectable fragment or cleavage part of the indicator molecule and (b) incapable of binding to the intact indicator molecule.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2016
From: DAVIS, PAUL; PAREKH, GITA; SCHOUTEN, JAMES
To: MOLOGIC LIMITED
Reel/Frame 038955/0915 →
Priority Claims (1)
GB 1318728.1 · Oct 23, 2013 · national
Continuity (1)
Related Publication 20160238596A1 · Aug 18, 2016